Navigation Links
Accumetrics Closes 2010 With Positive Outlook
Date:12/7/2010

nse to antiplatelet therapy," said Timothy I. Still, President and CEO of Accumetrics. "As market dynamics continue to shift with the introduction of new antiplatelet medications, and with Plavix going generic in the coming year, Accumetrics is poised to provide physicians with tools to support cost-effective clinical decision making."

Accumetrics experienced strong growth in 2010 across all of its sales channels.  The Company expects to conclude the year with roughly $18 million in annual revenue, and expects to be profitable in the second half of 2011. Accumetrics recently added Medicos Hirata in Japan and Science International Corporation in China to its global distribution network, which now includes partnerships with over 40 leading distributors who provide local representation in over 60 countries spanning Europe, the Americas, Asia-Pacific and the Middle East.  

Company financing in 2010 included a raise of an additional $7 million, securing a total of $24 million in new capital since 2009.  Proceeds are expected to take the company to profitability during 2011 and will fund a number of key milestones that will maintain Accumetrics' position as a diagnostic leader in the point-of-care market, including expanded claims for existing products, new product development and continued expansion of global commercialization efforts. 

About Accumetrics Accumetrics is committed to advancing medical understanding of platelet function and enhancing quality of care for patients receiving antiplatelet therapies by providing industry-leading and widely accessible diagnostic tests for rapid platelet function assessment.

Accumetrics' VerifyNow System is the first rapid and easy-to-use platform to help physicians determine an individual's response to multiple antiplatelet agents. Addressing every major antiplatelet drug, including FDA-cleared products for aspirin, P2Y12 inhibitors (e.g. prasugrel (Effient®) and clopidogre
'/>"/>

SOURCE Accumetrics
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Accumetrics Announces $28.8 Million Financing and Initiation of Pivotal Clinical Trial
2. Accumetrics Announces the Launch and First Patient Enrolled Into the GRAVITAS Trial
3. Accumetrics, Inc. Announces GRAVITAS Trial 50 Percent Enrolled
4. Accumetrics Announces $16.5M in New Capital Financing
5. Accumetrics to Present at the 21st Annual Piper Jaffray Health Care Conference
6. Accumetrics Closes 2009 with Positive Outlook
7. Accumetrics, Inc., Daiichi Sankyo, Inc. and Eli Lilly and Company Launch Strategic U.S. Collaboration
8. BioVascular Inc. Closes $10.87 Million Series C Financing
9. MabVax Therapeutics Closes Two Licensing Agreements With Sloan-Kettering Institute for Cancer Research
10. DNA Therapeutics Closes 2.2 Million EUR Series A Financing Round
11. Cognition Therapeutics Closes Series A Financing to Advance Drug Candidates for Alzheimers Disease
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/21/2014)... Aug. 21, 2014   Royal Philips ... announced it has received 510(k) clearance from the ... precision planning application for Transcatheter Aortic-Valve Implantation (TAVI) ... provides interventionalists with pre-procedural, high-precision positioning to treat ... planning application is available as part of Philips ...
(Date:8/21/2014)... 2014 Asterias Biotherapeutics, Inc. (OTCBB: ASTY), a ... medicine, announced today the appointments of Andrew ("Andy") Arno ... Board of Directors. With these additions, the Asterias Board ... are independent. Andy Arno , 55, ... companies. He is currently Managing Director of Emerging Growth ...
(Date:8/20/2014)... , Aug. 20, 2014  The National Association ... latest results achieved by the real-time, pseudoephedrine (PSE) ... National Precursor Log Exchange (NPLEx), automatically blocks unlawful ... down meth offenders and make arrests. Data released ... Indiana blocked the sale of more ...
Breaking Medicine Technology:Philips receives FDA 510(k) Clearance for TAVI Precision Treatment Planning Application 2Philips receives FDA 510(k) Clearance for TAVI Precision Treatment Planning Application 3Asterias Biotherapeutics Appoints Two Independent Directors and Announces Completion of Series A Common Stock Distribution 2Asterias Biotherapeutics Appoints Two Independent Directors and Announces Completion of Series A Common Stock Distribution 3Asterias Biotherapeutics Appoints Two Independent Directors and Announces Completion of Series A Common Stock Distribution 4Indiana's Stop-Sale System Achieves Significant Results In Battle Against Meth 2
... Findings from an international,multicenter, randomized, double-blind, placebo-controlled ... treatment of moderate to severe,plaque psoriasis will be ... meeting,of the World Congress of Dermatology, which takes ... Buenos Aires, Argentina. The presentation, entitled CNTO ...
... (Nasdaq: ARNA ) today announced positive preliminary ... in patients with chronic insomnia. APD125,is an orally ... being,evaluated in insomnia patients who have difficulty maintaining ... patients treated with APD125,experienced statistically significant improvements in ...
Cached Medicine Technology:Pivotal Ustekinumab (CNTO 1275) Phase 3 Data to Debut at World Congress of Dermatology Meeting 2Arena Pharmaceuticals Announces Positive Phase 2 Clinical Trial Results of APD125 for the Treatment of Insomnia 2Arena Pharmaceuticals Announces Positive Phase 2 Clinical Trial Results of APD125 for the Treatment of Insomnia 3Arena Pharmaceuticals Announces Positive Phase 2 Clinical Trial Results of APD125 for the Treatment of Insomnia 4Arena Pharmaceuticals Announces Positive Phase 2 Clinical Trial Results of APD125 for the Treatment of Insomnia 5Arena Pharmaceuticals Announces Positive Phase 2 Clinical Trial Results of APD125 for the Treatment of Insomnia 6Arena Pharmaceuticals Announces Positive Phase 2 Clinical Trial Results of APD125 for the Treatment of Insomnia 7
(Date:8/21/2014)... born at a low or very low birth weight ... 2 diabetes. The findings, which appear in Diabetes ... of type 2 diabetes in African American populations, which ... Researchers from Boston University,s Slone Epidemiology Center followed more ... Study over the course of 16 years, analyzing characteristics ...
(Date:8/21/2014)... -- Being born at a low birth weight puts black ... study suggests. The findings may partly explain high diabetes ... prevalence of low birth weight, the researchers added. Their ... with a low birth weight were 13 percent more likely ... birth weight. The risk of diabetes was 40 percent higher ...
(Date:8/21/2014)... New York (PRWEB) August 21, 2014 ... against C.R. Bard, Inc. continue to move forward ... District Court, Southern District of West Virginia, Bernstein ... issued on August 14th, the Court has established ... that requires special handling, division, storage and preservation. ...
(Date:8/21/2014)... rural communities do not routinely screen women for ... medical and public health researchers. Rural women who ... if they seek help., "Rural health care providers ... S. McCall-Hosenfeld, a primary care physician and assistant ... State College of Medicine. "However, in rural settings, ...
(Date:8/21/2014)... The world wound care market is ... and reach USD 18.3 billion by 2019, posting a ... of such growth include governments’ contribution to the development ... and surging ageing population. However, the growth could be ... Region-wise, North America leads the global wound care market, ...
Breaking Medicine News(10 mins):Health News:Low birth weight linked to higher incidence of type 2 diabetes in African American women 2Health News:Low Birth Weights May Put Black Women at Risk for Diabetes 2Health News:Transvaginal Mesh Lawsuits Move Forward in Federal C.R. Bard Litigation with Issuance of New Pretrial Order, Bernstein Liebhard LLP Reports 2Health News:Transvaginal Mesh Lawsuits Move Forward in Federal C.R. Bard Litigation with Issuance of New Pretrial Order, Bernstein Liebhard LLP Reports 3Health News:Primary care physicians can be critical resource for abused women in rural areas 2Health News:Global Wound Care Market to Post 3.2% CAGR Through 2019, Says MarketsandMarkets in Its New Report Published at MarketPublishers.com 2Health News:Global Wound Care Market to Post 3.2% CAGR Through 2019, Says MarketsandMarkets in Its New Report Published at MarketPublishers.com 3
... U-M physician include economical options , , ... of cologne, a new pair of pajamas or a video game are ... holiday season. But this year, why not give something more healthy and ... , , Staying healthy around the ...
... Christopher Horvath, D.V.M., as Vice President of Preclinical Sciences ... , , CAMBRIDGE, Mass., ... Cambridge, Mass.-based executive team with the appointment of Jeffrey ... also announced the additions of Christopher Horvath, D.V.M., as ...
... December, Anthem Blue,Cross is giving the gift of health ... the state offering free health evaluations. Launching,on Monday, ... California,the bus will depart on a multi-city tour to ... Francisco (see detailed schedule,below). , ...
... College 2008 Dreams Come True event. , ... New York, NY (PRWEB) ... sponsor a U.S. chapter of KCA College for Keep A Child Alive, ... the world. KCA College is an action-oriented network of college students ...
... portal, HeadHunterHealthExchange.com allows employers and recruiters to use just one ... candidates online to jobs posted by different employers across the ... hiring more efficent. The Exchange simplifies and expedites the hiring ... ...
... the Dec. 1 issue of the journal Sleep ... and a strict sleep schedule can help night-shift workers create ... performance and alertness during night shifts while still allowing adequate ... performance was better for the experimental subjects than the controls. ...
Cached Medicine News:Health News:Giving the Gift of Health This Holiday Season 2Health News:Giving the Gift of Health This Holiday Season 3Health News:Giving the Gift of Health This Holiday Season 4Health News:Taligen Therapeutics Advances Corporate Growth Plan with Appointment of Jeffrey T. Walsh as Chief Business Officer 2Health News:Taligen Therapeutics Advances Corporate Growth Plan with Appointment of Jeffrey T. Walsh as Chief Business Officer 3Health News:Anthem Blue Cross Gives the Gift of Health to California 2Health News:Anthem Blue Cross Gives the Gift of Health to California 3Health News:My Bank Tracker Sponsors "Keep A Child Alive" 2Health News:HeadHunterHealthExchange.com Launched to Enhance Healthcare Recruitment for Employers and Recruiters 2Health News:HeadHunterHealthExchange.com Launched to Enhance Healthcare Recruitment for Employers and Recruiters 3Health News:Study shows how shift workers can improve job performance and implement a realistic sleep schedule 2Health News:Study shows how shift workers can improve job performance and implement a realistic sleep schedule 3
... Drapes have aggressive adhesive with no ... adhesion. It's made of thin, low ... with allow-glare matte finish film. Includes ... ,Available sterile in a box of ...
... procedure drape made of 3M™ Steri-Drape™ Absorbent ... create a sterile field during procedures on ... and convenient by eliminating the need for ... extremity drapes with elastic apertures suitable for ...
The Abbott Commander is an automated, high-throughput immunoassay testing system. The Commander System consists of the Flexible Pipetting Center, the Parallel Processing Center, and the Dynamic Incub...
... sample preparation platform is an efficient system ... from patient samples using novel magnetic particle ... sample preparation and is cabable of processing ... a 1 ml sample volume., ,This platform ...
Medicine Products: